Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Clin Immunol. 2011 Dec 30;142(3):351–361. doi: 10.1016/j.clim.2011.12.006

Fig. 7. LNFPIII treatment induces little production of pro-inflammatory factors.

Fig. 7

CD11b+Ly-6Chi inflammatory monocytes (IMCs) from CFA/PT immunized B6 mice were loaded 1×105 cells/well, and treated with 20 ng/ml GM-CSF, together with 50 μg/ml dextran, 50 μg/ml LNFPIII, or 100 ng/ml LPS as indicated for 48 h. Cytokine/chemokine concentrations in the supernatants were examined. Data are representative for 2 independent experiments.